Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 25 May 1973:
Vol. 180. no. 4088, pp. 871 - 872
DOI: 10.1126/science.180.4088.871
Prev | Table of Contents | Next

Articles

Autoimmune Response to Acetylcholine Receptor

Jim Patrick 1 and Jon Lindstrom 1

1 Neurobiology Department, Salk Institute, San Diego, California 92112

Injection of rabbits with acetylcholine receptor highly purified from the electric organ of Electrophorus electricus emulsified in complete Freund's adjuvant resulted in the production of precipitating antibody to acetylcholine receptor. After the second injection of antigen, the animals developed the flaccid paralysis and abnormal electromyographs characteristic of neuromuscular blockade. Treatment with the anticholinesterases edrophonium or neostigmine dramatically alleviated the paralysis and the fatigue seen in electromyography.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Effect of Plasma From Muscle-Specific Tyrosine Kinase Myasthenia Patients on Regenerating Endplates.
W. P. ter Beek, P. Martinez-Martinez, M. Losen, M. H. de Baets, A. R. Wintzen, J. J.G.M. Verschuuren, E. H. Niks, S. G. van Duinen, A. Vincent, and P. C. Molenaar (2009)
Am. J. Pathol. 175, 1536-1544
   Abstract »    Full Text »    PDF »
'Seronegative' myasthenia gravis is no longer seronegative.
J. Lindstrom (2008)
Brain 131, 1684-1685
   Full Text »    PDF »
Perivascular infiltrate of memory lymphocytes and mature dendritic cells in MG thymomas.
Y. Nagane, K. Utsugisawa, H. Akutsu, Y. Sato, and Y. Terayama (2005)
Neurology 65, 770-772
   Abstract »    Full Text »    PDF »
How the Monoamine Transporter Garden Grows.
A. E. Ruoho (2005)
Mol. Pharmacol. 68, 272-274
   Abstract »    Full Text »    PDF »
Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia.
C. Vandiedonck, G. Beaurain, M. Giraud, C. Hue-Beauvais, B. Eymard, C. Tranchant, P. Gajdos, J. Dausset, and H.-J. Garchon (2004)
PNAS 101, 15464-15469
   Abstract »    Full Text »    PDF »
Passive Transfer of Autoimmune Autonomic Neuropathy to Mice.
S. Vernino, L. G. Ermilov, L. Sha, J. H. Szurszewski, P. A. Low, and V. A. Lennon (2004)
J. Neurosci. 24, 7037-7042
   Abstract »    Full Text »    PDF »
Experimental Autoimmune Autonomic Neuropathy.
S. Vernino, P. A. Low, and V. A. Lennon (2003)
J Neurophysiol 90, 2053-2059
   Abstract »    Full Text »    PDF »
Anti-Titin Antibodies in Myasthenia Gravis: Tight Association With Thymoma and Heterogeneity of Nonthymoma Patients.
A. M. Yamamoto, P. Gajdos, B. Eymard, C. Tranchant, J.-M. Warter, L. Gomez, C. Bourquin, J.-F. Bach, and H.-J. Garchon (2001)
Arch Neurol 58, 885-890
   Abstract »    Full Text »    PDF »
The Role of Adjuvants in the Efficacy of a Peptide Vaccine for Myasthenia Gravis.
J. L. McAnally, L. Xu, M. Villain, and J. E. Blalock (2001)
Experimental Biology and Medicine 226, 307-311
   Abstract »    Full Text »
A peptide vaccine that prevents experimental autoimmune myasthenia gravis by specifically blocking T cell help.
S. ARAGA, L. XU, K. NAKASHIMA, M. VILLAIN, and J. E. BLALOCK (2000)
FASEB J 14, 185-196
   Abstract »    Full Text »
TE671 Cell-based ELISA for Anti-Acetylcholine Receptor Antibody Determination in Myasthenia Gravis.
D. Franciotta, G. Martino, E. Brambilla, E. Zardini, V. Locatelli, A. Bergami, C. Tinelli, G. Desina, and V. Cosi (1999)
Clin. Chem. 45, 400-405
   Abstract »    Full Text »    PDF »
Myasthenia gravis.
R. Hohlfeld (1999)
Neurology 52, 443
   Full Text »
Mimicry between Receptors and Antibodies. IDENTIFICATION OF SNAKE TOXIN DETERMINANTS RECOGNIZED BY THE ACETYLCHOLINE RECEPTOR AND AN ACETYLCHOLINE RECEPTOR-MIMICKING MONOCLONAL ANTIBODY.
F. Ducancel, K. Merienne, C. Fromen-Romano, O. Tremeau, L. Pillet, P. Drevet, S. Zinn-Justin, J.-C. Boulain, and A. Menez (1996)
J. Biol. Chem. 271, 31345-31353
   Abstract »    Full Text »    PDF »
Myasthenia Gravis.
D. B. Drachman (1994)
N. Engl. J. Med. 330, 1797-1810
   Full Text »
Immunologic Aspects of Neurological and Neuromuscular Diseases.
B. Zweiman and A. I. Levinson (1992)
JAMA 268, 2918-2922
   Abstract »    PDF »
High-Dose Intravenous Immunoglobulin in the Management of Myasthenia Gravis.
E. L. Arsura, A. Bick, N. G. Brunner, T. Namba, and D. Grob (1986)
Arch Intern Med 146, 1365-1368
   Abstract »    PDF »
High-Dose Intravenous Methylprednisolone in Myasthenia Gravis.
E. Arsura, N. G. Brunner, T. Namba, and D. Grob (1985)
Arch Neurol 42, 1149-1153
   Abstract »    PDF »
Acetylcholine receptor: an allosteric protein.
J. Changeux, A Devillers-Thiery, and P Chemouilli (1984)
Science 225, 1335-1345
   Abstract »    PDF »
Myasthenia Gravis in Monozygotic Twins: Clinical Follow-up Nine Years After Thymectomy.
N. Allen, P. Kissel, D. Pietrasiuk, and M. J. Perlow (1984)
Arch Neurol 41, 994-996
   Abstract »    PDF »
Myasthenia Gravis: A Clinical and Basic Science Review.
M. E. Seybold (1983)
JAMA 250, 2516-2521
   Abstract »    PDF »
Mammalian muscle acetylcholine receptor: a supramolecular structure formed by four related proteins.
B. Conti-Tronconi, C. Gotti, M. Hunkapiller, and M. Raftery (1982)
Science 218, 1227-1229
   Abstract »    PDF »
Immunologic Aspects of Neurological and Neuromuscular Diseases.
J. N. Fink and B. G. W. Arnason (1982)
JAMA 248, 2710-2715
   Abstract »    PDF »
Steroid Treatment for Experimental Autoimmune Myasthenia Gravis.
D. A. Barone, D. H. Lambert, and C. M. Poser (1980)
Arch Neurol 37, 663-666
   Abstract »    PDF »
Anastomoses of Transverse Tubules With Terminal Cisternae in Polymyositis.
S. M. Chou, I. Nonaka, and G. F. Voice (1980)
Arch Neurol 37, 257-266
   Abstract »    PDF »
Dagen des Oordeels: Pathokinetic Mechanisms and Molecular Messengers (A Dramatic View).
W. K. Engel (1979)
Arch Neurol 36, 329-339
   Abstract »    PDF »
Clinical Syndromes of Myasthenia in Infancy and Childhood: A Review.
G. M. Fenichel (1978)
Arch Neurol 35, 97-103
   Abstract »    PDF »
Binding of Iodine 125 {alpha}-Bungarotoxin to the Thymus of Mice.
F. Ohshima, K. Kondo, and T. Tsubaki (1978)
Arch Neurol 35, 31-32
   Abstract »    PDF »
Myasthenic immunoglobulin accelerates acetylcholine receptor degradation.
I Kao and D. Drachman (1977)
Science 196, 527-529
   Abstract »    PDF »
Experimental Autoimmune Myasthenia Gravis in Rats: Modification by Thymectomy and Prednisolone.
D. B. Sanders, T. R. Johns, M. E. Eldefrawi, and E. E. Cobb (1977)
Arch Neurol 34, 75-79
   Abstract »    PDF »
Receptors for Peptide Hormones: New Insights into the Pathophysiology of Disease States in Man.
C. R. KAHN, K. MEGYESI, R. S. BAR, R. C. EASTMAN, and J. S. FLIER (1977)
Ann Intern Med 86, 205-219
   Abstract »    PDF »
Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis.
I Kao and D. Drachman (1977)
Science 195, 74-75
   Abstract »    PDF »
Acetylcholine Receptor Protein: Neuromuscular Transmission in Immunized Rabbits.
D. Elmqvist, C. Mattsson, E. Heilbronn, H. Lundh, and R. Libelius (1977)
Arch Neurol 34, 7-11
   Abstract »    PDF »
Blockade of prolactin action by an antiserum to its receptors.
R. Shiu and H. Friesen (1976)
Science 192, 259-261
   Abstract »    PDF »
Reversal of acetylcholine potentials in eel electroplaque.
N. Lassignal and A. Martin (1976)
Science 191, 464-466
   Abstract »    PDF »
Facets of the Structures of Acetylcholine Receptors from Electrophorus and Torpedo.
A. Karlin, C. L. Weill, M. G. McNamee, and R. Valderrama (1976)
Cold Spring Harb Symp Quant Biol 40, 203-210
   Abstract »    PDF »
Some Structural Properties of the Cholinergic Receptor Protein in Its Membrane Environment Relevant to Its Function as a Pharmacological Receptor.
J.-P. Changeux, L. Benedetti, J.-P. Bourgeois, A. Brisson, J. Cartaud, P. Devaux, H. Grunhagen, M. Moreau, J.-L. Popot, A. Sobel, et al. (1976)
Cold Spring Harb Symp Quant Biol 40, 211-230
   Abstract »    PDF »
Myasthenia gravis: passive transfer from man to mouse.
K. Toyka, D. Brachman, A Pestronk, and I Kao (1975)
Science 190, 397-399
   Abstract »    PDF »
Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance.
J. Flier, C. Kahn, J Roth, and R. Bar (1975)
Science 190, 63-65
   Abstract »    PDF »
Myasthenia Gravis and Acetylcholine Receptor: Effect of Steroids in Clinical Course and Cellular Immune Response to Acetylcholine Receptor.
O. Abramsky, A. Aharonov, D. Teitelbaum, and S. Fuchs (1975)
Arch Neurol 32, 684-687
   Abstract »    PDF »
Coexistent Myasthenia Gravis and Hypopituitarism.
C. L. Walters, J. O. Susac, A. D. Huott, and D. L. Conaway (1975)
JAMA 231, 1228-1229
   Abstract »    PDF »
Blockade of acetylcholine receptors: a model of myasthenia gravis.
S Satyamurti, D. Drachman, and F Slone (1975)
Science 187, 955-957
   Abstract »    PDF »
Serum Globulin in Myasthenia Gravis: Inhibition of agr-Bungarotoxin Binding to Acetylcholine Receptors.
R. R. Almon, C. G. Andrew, and S. H. Appel (1974)
Science 186, 55-57
   Abstract »    PDF »
Myasthenia Gravis.
W. K. ENGEL, B. W. FESTOFF, B. M. PATTEN, M. L. SWERDLOW, H. H. NEWBALL, and M. D. THOMPSON (1974)
Ann Intern Med 81, 225-246
   Abstract »    PDF »
Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice.
M. Paas-Rozner, M. Dayan, Y. Paas, J.-P. Changeux, I. Wirguin, M. Sela, and E. Mozes (2000)
PNAS 97, 2168-2173
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)